Search

Your search keyword '"Soraru', G"' showing total 194 results

Search Constraints

Start Over You searched for: Author "Soraru', G" Remove constraint Author: "Soraru', G"
194 results on '"Soraru', G"'

Search Results

3. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

4. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

5. 271st ENMC international workshop: Towards a unifying effort to fight Kennedy's disease. 20-22 October 2023, Hoofddorp, Netherlands

6. Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on disease

7. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

8. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

9. Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An 18F-FDG PET/MRI Study

10. Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome

12. Empathy-based supportive treatment in amyotrophic lateral sclerosis: A pragmatic study

17. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy

22. Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)

25. Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)

27. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

28. Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis

30. Factors predicting survival in ALS: a multicenter Italian study

34. SiBOC ceramic fibers via pyrolysis of hybrid borosiloxane gel fibers

35. 24-Holter ECG in type II and III SMA

36. Morandi. Phase II multicentric double-blind placebo controlled study of tolerability and efficacy of salbutamol in adult type III patients

50. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy

Catalog

Books, media, physical & digital resources